During the past decade, Diabetes & Endocrinology Consultants, PC conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 25 clinical trials were completed, i.e. on average, 67.6% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 17 clinical trials were completed. i.e. 141.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Diabetes & Endocrinology Consultants, PC" #1 sponsor was "Eli Lilly and Company" with 6 trials, followed by "Allergan" with 5 trials sponsored, "AstraZeneca" with 4 trials sponsored, "Kowa Research Institute, Inc." with 4 trials sponsored and "Boehringer Ingelheim" with 4 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Diabetes & Endocrinology Consultants, PC" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Integrated Medical Development" with 1 trials as a collaborator and "Juvenile Diabetes Research Foundation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Diabetes & Endocrinology Consultants, PC" are "Type 2 Diabetes" (6 trials), "Diabetes Mellitus" (5 trials), "Gastroparesis" (5 trials), "Diabetes Mellitus, Type 1" (4 trials) and "Diabetes Mellitus, Type 2" (3 trials). Many other conditions were trialed in "Diabetes & Endocrinology Consultants, PC" in a lesser frequency.

Most popular intervention types in "Diabetes & Endocrinology Consultants, PC" are "Drug" (41 trials), "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "Relamorelin" (4 trials), "Dapagliflozin" (3 trials), "Dulaglutide" (3 trials) and "K-877" (3 trials). Other intervention names were less common.

The vast majority of trials in "Diabetes & Endocrinology Consultants, PC" are 45 trials for "All" genders.

Currently, there are NaN active trials in "Diabetes & Endocrinology Consultants, PC". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Diabetes & Endocrinology Consultants, PC, 1 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Diabetes & Endocrinology Consultants, PC, 2 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".

Diabetes & Endocrinology Consultants, PC has several departments that took part in Clinical trials: "The Coleman Radiation Center-Carteret General Hospital" - 4 trials, "Carteret Health Care Cancer Center" - 2 trials